HOME >> MEDICINE >> NEWS
New awards, expanded focus for Pediatric AIDS Clinical Trials Group

The National Institute of Allergy and Infectious Diseases (NIAID) today announced $36 million in renewed funding for the Pediatric AIDS Clinical Trials Group (PACTG), and a greater focus on both adolescent research and international pediatric research. The new five-year awards will support 18 university-based clinical trials sites, a statistical and data management center, and a coordinating and operations center.

The PACTG has pioneered key trials evaluating treatments for children with HIV and has made great advances in reducing the rate of mother-to-infant HIV transmission in the developed world. The epidemic among adolescents in the United States, however, has become an increasing concern. The Centers for Disease Control and Prevention reports that 4,219 cumulative cases of AIDS among adolescents, or children ages 13 through 19, were reported through June 2001,(1) and the number of adolescents living with HIV is estimated to be much higher.

Because the average length of time between HIV infection and the development of AIDS is 10 years, it is believed that many adults became infected as adolescents. Most adolescents infected with HIV are at an early stage of disease and are ideal candidates for early intervention and treatment strategies.

HIV and AIDS also continue to take a devastating toll on women and children in developing countries, where more than 90 percent of all HIV/AIDS cases occur. In 2001, approximately 2.7 million children younger than age 15 were living with HIV/AIDS worldwide, and 580,000 children in this age group died from HIV-associated illnesses or AIDS, according to a UNAIDS report.(2) In addition to the suffering of children, 48 percent of adults living with HIV/AIDS in the world are women, many of whom are of childbearing age.(2) To this end, the PACTG will also directly support clinical research at four international sites, two in South Africa and two in Thailand.

"The Pediatric AIDS Clinical Trials
'"/>

Contact: Diana K. Carroll
dcarroll@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
7-Mar-2002


Page: 1 2 3 4 5

Related medicine news :

1. Routine HIV screening should be expanded, study finds
2. Partnership for Prevention and ACPM commend expanded coverage of preventive services under Medicare
3. Study of energy and health in Africa focuses spotlight on charcoal and forest management
4. Protecting human subjects focus of national FDA conference at UH
5. Non-lethal weapons focus of research study
6. Insulin resistance intervention after stroke focus of $33 million grant
7. Ethics of neuroimaging research to be focus of NIH/Stanford meeting
8. TIGER Workshop puts focus on space for African water management
9. UCI launches nations first medical education program focused on Latino culture
10. New initiative to focus on growing problem of cardiovascular disease in diabetics
11. Apraxia of speech in children is focus of new OHSU grant

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New awards expanded focus for Pediatric AIDS Clinical Trials Group

(Date:7/7/2015)... , ... July 07, 2015 ... ... on highly educated and motivated leaders with strong managerial expertise to oversee ... clearly communicate with patients, staff, providers, business partners, insurance companies, and regulators. ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... an official accrediting body as designated by the Centers for Medicare and Medicaid ... experience and to enhance compatibility with mobile devices. , The most effective websites ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... a leading provider of unified communication management solutions, has announced the release ... Select. , This service pack includes a number of enhancements to the ...
(Date:7/7/2015)... MO (PRWEB) , ... July 07, 2015 , ... ... liability law announce the launch of their new website, the Invokana Ketoacidosis ... Invokana FDA warning*, and serves as a resource for persons wishing to learn ...
(Date:7/7/2015)... ... ... On May 29, 2015, Health Canada announced that they had registered a ... gluten free oats and foods that contain them as ingredients. , “We are very ... include gluten-free oat products in Canada,” says Frank Massong, VP of Regulatory and Technical ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4
(Date:7/6/2015)... PITTSBURGH , July 6, 2015  Student-athletes ... will benefit from a recently established partnership ... California . The partnership enables ... (S.A.I.N.) to distribute ImPACT ® concussion baseline ... insures the majority of community colleges in ...
(Date:7/6/2015)... , July 6, 2015  Array BioPharma ... its Chief Executive Officer, Ron Squarer , ... Conference in New York City.  The public is ... webcast on the Array BioPharma website. Event: Cantor Fitzgerald ... 8, 2015Time:1:00 p.m. Eastern Time Webcast: www.arraybiopharma.com About ...
(Date:7/6/2015)... July 6, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... and cancellation of its previously announced underwritten public offering ... of $0.87 per unit. Canaccord Genuity ... Group was acting as co-manager for the offering. ...
Breaking Medicine Technology:California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 2California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 3EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2
Cached News: